The IPO of Attovia Therapeutics, Inc. on NASDAQ marks the company's first public offering of shares, enabling investors to purchase equity stakes and allowing the company to raise capital from public markets. Market participants monitor IPO activity because it reflects capital-raising dynamics in the biotech sector, investor sentiment toward emerging companies, and broader capital market momentum.